1. Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, Humphrey MB, Lane NE, Magrey M, Miller M, Morrison L. 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid‐Induced osteoporosis. Arthritis & rheumatology. 2017 Aug;69(8):1521-37.
2. Ilias I, Zoumakis E, Ghayee H. An Overview of Glucocorticoid Induced Osteoporosis. [Updated 2018 Jul 10]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000-. https://www.ncbi.nlm.nih.gov/books/NBK278968/?report=classic
3. Hu K, Adachi JD. Glucocorticoid induced osteoporosis. Expert review of endocrinology & metabolism. 2019 Jul 4;14(4):259-66.
4. Compston J. Glucocorticoid-induced osteoporosis: an update. Endocrine. 2018 Jul;61(1):7-16.
5. Song BW, Kim AR, Kim MA, Kim HS, Lee SG. Status of Glucocorticoid-Induced Osteoporosis Preventive Care in Korea: A Retrospective Cohort Study on the Korean National Health Insurance Service Database. Medicina. 2022 Feb;58(2):324.
6. Cherian KE, Kapoor N, Paul TV. Glucocorticoid-induced osteoporosis. Indian journal of endocrinology and metabolism. 2017 Sep;21(5):652.
7. Hayes KN, Baschant U, Hauser B, Burden AM, Winter EM. When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis. Frontiers in endocrinology. 2021;12.
8. Amiche MA, Lévesque LE, Gomes T, Adachi JD, Cadarette SM. Effectiveness of oral bisphosphonates in reducing fracture risk among oral glucocorticoid users: three matched cohort analyses. Journal of Bone and Mineral Research. 2018 Mar;33(3):419-29.
9. Wong SP, Mok CC. Management of glucocorticoid-related osteoporotic vertebral fracture. Osteoporosis and Sarcopenia. 2020 Mar 1;6(1):1-7.
10. Adami G, Saag KG. Glucocorticoid-induced osteoporosis update. Current opinion in rheumatology. 2019 Jul 1;31(4):388-93.